Skip to main content

What the FDA labels say about taking them together

Atogepant and itraconazole

Atogepant's FDA label of September 30, 2025 names itraconazole in its drug interactions section; the itraconazole labels PlainMeds reads (2) do not name atogepant. The atogepant label: “Coadministration of QULIPTA with itraconazole, a strong CYP3A4 inhibitor, resulted in a significant increase in exposure of atogepant in healthy subjects.”

Check it at the source: the atogepant FDA label on DailyMed (effective September 30, 2025, AbbVie Inc.); the itraconazole FDA label on DailyMed (effective July 13, 2026, Janssen Pharmaceuticals, Inc.).

What does the atogepant label say about itraconazole?

Atogepant label, drug interactions

Coadministration of QULIPTA with itraconazole, a strong CYP3A4 inhibitor, resulted in a significant increase in exposure of atogepant in healthy subjects [see Clinical Pharmacology ( 12.3 )].

Source: FDA drug label (Qulipta), AbbVie Inc., effective September 30, 2025 (SPL set 8c8ab8f4-32bd-497a-befa-70c8a51d8d52), via openFDA; the full label on DailyMed

What does the itraconazole label say about atogepant?

Itraconazole's label (effective July 13, 2026) and its 1 other brand-application label do not name atogepant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SPORANOX), Janssen Pharmaceuticals, Inc., effective July 13, 2026 (SPL set a4d555fa-787c-40fb-bb7d-b0d4f7318fd0), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Atogepant generic labelers
11Itraconazole generic labelers
AtogepantItraconazole
Labeled forMigraineFungal infections
Boxed warningNoYes
Pharmacy cost (NADAC)$38.36 per tablet 10 mg tablet$0.910 per capsule 100 mg capsule
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?